For patients with chronic  hepatitis  B, the protective effects of  aspirin  against  hepatocellular carcinoma  (HCC) can vary with  cirrhosis  status and statin treatment, a pair of new studies finds.

One study showed that although aspirin is linked to a reduction in risk for HCC in these patients, comedication with statins ...